Cocultures of metastatic and host immune cells: Selective effects of NAMI-A for tumor cells

Cancer Immunology, Immunotherapy

Volumn 53, Issue 12, 2004, Pages 1101-1110

  Bacac, Marina ^a   Vadori, Marta ^a   Sava, Gianni ^a   Pacor, Sabrina ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Cell cycle; Cocultures; Host immune cells; Metastatic cells; Mitochondrial functionality; NAMI A

Indexed keywords

ANTINEOPLASTIC AGENT; CONCANAVALIN A; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RUTHENIUM COMPLEX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOBLAST; CELL ADHESION; CELL COUNT; CELL CYCLE; CELL CYCLE S PHASE; CELL MEMBRANE DEPOLARIZATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; DIPLOIDY; DRUG EFFECT; DRUG SELECTIVITY; HOST; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LEUKOCYTE; LYMPHOCYTE; MALE; METASTASIS; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SPLEEN CELL; T LYMPHOBLAST; THYMOCYTE; TUMOR CELL;

ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; CELL CYCLE; COCULTURE TECHNIQUES; DIMETHYL SULFOXIDE; LYMPHOCYTES; MALE; MICE; MICE, INBRED CBA; MICROSCOPY, ELECTRON, SCANNING; NEOPLASM METASTASIS; NITRIC OXIDE; ORGANOMETALLIC COMPOUNDS;

EID: 8644250472     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-004-0566-0     Document Type: Article

References (33)

1. Applegate KG, Balch CM, Pellis NR (1990) In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes. Cancer Res 22:7153
2. Beltran B, Quintero M, Garcia-Zaragoza E, O'Connor E, Esplugues JV, Moncada S (2002) Inhibition of mitochondrial respiration by endogenous nitric oxide: a critical step in Fas signaling. PNAS 99:8892
3. Bourguignon LYW (2001) CD44-mediated oncogenic signalling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neopl 6:287
4. Bourguignon LYW, Zhu H, Shao L, Chen YW (2001) CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid (HA)-dependent ovarian tumor cell migration. J Biol Chem 276:7327
5. Cocchietto M, Sava G (2000) Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice. Pharmacol Toxicol 87:193
6. Cossarizza A, Baccarani Contri M, Kalashnikova G, Francheschi C (1993) A new method for cytofluorimetric analysis of mitochondrial membrane potential using J-aggregate forming lipohphilic cation 5, 5′,6, 6′- tetrachloro-1, 1′,3,3′- tetraethylbenzimidazol-carbocyanineiodide (JC-1). Biochem Biophys Res Commun 197:40
7. Cossarizza A, Ceccarelli D, Masini A (1996) Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorimetric analysis at the single organelle level. Exp Cell Res 222:84
8. DeGrendele HC, Estess P, Siegelman MH (1997) Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278:672
9. DHHS (1985) Guide for the care and use of laboratory animals. Department of Health and Human Services, National Institutes of Health, Bethesda, MD, p 23
10. Foss FM (2002) Immunologic mechanisms of antitumor activity. Semin Oncol 29:5
11. Goldberg EP, Hasdba AR, Almond BA, Marotta JS (2002) Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preperative drug delivery. J Pharm Pharmacol 54:159
12. Haynes BF, Telen MJ, Hale LP, Denning SM (1989) CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:423
13. Hammond D, Nagarkatti PS, Gote L, Seth A, Hassuneh M, Nagarkatti M (1993) Double-negative T cells from MRL-1pr/ 1pr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perforin gene. J Exp Med 178:2225
14. Liotta LA, Kohn EC (2001) The microenvironment of the tumor-host interface. Nature 411:375
15. Mackall CL (1999) T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review. Oncologist 4:370
16. Magnarin M, Bergamo A, Carotenuto ME, Zorzet S, Sava G (2000) Increase of tumor infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A. Anticancer Res 20:2939
17. Marlin SD, Springer TA (1987) Purified intercellular adhesion molecule (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 51:813
18. Noble PW, Lake LR, Henson PM, Riches DW (1993) Hyaluronate activation of CD44 induces insulin like growth factor 1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 91:2368
19. Novak AK, Bruce W, Robinson S, Lake RA (2002) Gemcitabine exerts a selective effect on the humoral immune response implications for combination chemo-immunotherapy. Cancer Res 62:2353
20. Pacor S, Vadori M, Vita F, Bacac M, Soranzo MR, Zabucchi G, Sava G (2001) Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A. Anticancer Res 21:2523
21. Pacor S, Cocchietto M, Zorzet S, Bacac M, Vadori M, Castellarin A, Turrin C, Sava G (2004) Intra-tumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and TIL recruitment. J PET (in press)
22. Pintus G, Tadolini B, Posadino AM, Sanna B, Debidda M, Bennardini F, Sava G, Ventura C (2002) Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down-regulates c-myc gene expression and endothelial cell proliferation. Eur J Biochem 269:5861
23. Poliak-Blazi M, Boranic M, Marzan B, Radacic M (1986) A transplantable aplastic mammary carcinoma of CBA mice. Vet Arh 51:99
24. Rafi A, Nagarkatti M, Nagarkatti PS (1997) CD44-hyaluronic acid interactions in B lymphocyte cell activation. Blood 89:2901
25. Reimann T, Buscher D, Hipskind RA, Krautwald S, Lohmann-Matthes ML, Baccarini M (1994) Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway: a putative role for Raf-1 in the induction of the IL-1 beta and the TNF-alpha genes. J Immunol 153:5740
26. Sava G, Bergamo A (2000) Ruthenium-based compounds and tumor growth control. Int J Oncol 17:353
27. Sava G, Capozzi I, Clerici K, Gagliardi R, Alessio E, Mestroni G (1998) Pharmacological control of lung metastases of solid tumors by a novel ruthenium complex. Clin Exp Met 16:371
28. Sava G, Zorzet S, Turrin C, Vita F, Soranzo M, Zabucchi G, Cocchietto M, Bergamo A, DiGiovine S, Pezzoni G, Sartor L, Garbisa S (2003) Dual action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen. Clin Cancer Res 9:1898
29. Sconocchia G, Campagnano L, Adorno D, Iacona A, Cococcetta NY, Boffo V, Amadori S, Casciani CU (2001) CD44 ligation on peripheral blood polymorphonuclear cells induces interleukin-6 production. Blood 97:3621
30. Stahnke K, Fulda S, Friesen C, Straub G, Debatin KM (2001) Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy. Blood 98:3066
31. Stamenkovic I (2000) Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10:415
32. Stuehr DJ, Nathan CF (1989) Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169:1543
33. Teshigawara K, Okubo Y, Sugie K, Uchida A (1994) The regulation of NK cell activity through LFA-1 and p58. Clin Immunol Immunopathol 26:629